1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Invitae Acquires Jungla

M&A Deal Summary

Invitae Acquires Jungla

On July 11, 2019, Invitae acquired internet software and services company Jungla for 50M USD

Acquisition Highlights
  • This is Invitae’s 1st transaction in the Internet Software and Services sector.
  • This is Invitae’s 6th largest (disclosed) transaction.
  • This is Invitae’s 6th transaction in the United States.
  • This is Invitae’s 4th transaction in California.

M&A Deal Summary
Date 2019-07-11
Target Jungla
Sector Internet Software and Services
Buyer(s) Invitae
Deal Type Add-on Acquisition
Deal Value 50M USD

Target

Jungla

San Francisco, California, United States
Jungla, Inc. is a cloud-based platform that combines clinical knowledge with advances in functional genomics, biophysics, cellular engineering, machine learning, and distributed systems to help clinicians and patients understand the results of genetic and genomic tests.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Invitae

San Francisco, California, United States
Category Company
Founded 2010
Sector Life Science
Employees1,700
Revenue 516M USD (2022)
DESCRIPTION

Invitae is a genetic information company diagnostics for hereditary disorders. Invitae was founded in 2010 and is based in San Francisco, California.

DEAL STATS #
Overall 6 of 13
Sector: Internet Software and Services M&A 1 of 1
Type: Add-on Acquisition M&A Deals 6 of 13
State: California M&A 4 of 6
Country: United States M&A 6 of 12
Year: 2019 M&A 2 of 3
Size (of disclosed) 6 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-06-17 Singular Bio

San Francisco, California, United States

Singular Bio, Inc. provides single molecule detection technology that enables lower costs and expanded use of high-quality, cell-free, nucleic acid analysis, initially for application in non-invasive prenatal screening (NIPS). Singular Bio, Inc. was founded in 2012 and is based in San Francisco, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-11-11 Clear Genetics

San Francisco, California, United States

Clear Genetics, Inc. is a Y Combinator company and provider in developing innovative, patient-centric software to thoughtfully integrate genetics into routine patient care. Clear Genetics, Inc. is based in San Francisco, California.

Buy $50M
Mergr

Solution for

Product

Company

Legal